Sponsors: []Modifications: IIIincluded in Schedules II through V(i)(ii)mayexcept under Subsection (3)(a)(i)(iii)under this Subsection (3)(a)(A)(B)(C)(D)(E)(F)unless:(i)  the person to whom the prescription is issued is licensed under Subsection (2); and(ii)  the prescribed controlled substance is to be used in research.Full text:



Utah State Legislature












Legislators

By Session (1896-Current)
Alphabetical (Historical)
Find by Address/Map
More


Bills

Bills/Bill Requests
Passed Bills
2017 Bills

Keyword Search
Reading Calendars
Tracking Service
More


Committees

All Committees
Appropriations
Commissions

Independent Legislative Ethics Commission
Interim
Standing
Subcommittees
Task Forces
Bills In Committees


Utah Code / Constitution


Title/Chapter/Section
Keyword Search 

Utah Constitution
Laws of Utah 1851-ongoing
Utah Territorial Laws 
More


Senate

Main Page 
About The Senate 
Leadership 
Roster 
Seating Chart 
District Maps 
Extraordinary Sessions 
Reading Calendars 
Past Floor Debates 
Senate Journals 


House

Main Page
About the House 
Leadership 
Roster 
Seating Chart 
District Maps 
Reading Calendars 
Past Floor Debates 
Journals 
Conflict of Interest Forms 


Legislative Guide 

Legislative Guide
Civic Programs
GRAMA (Records Requests)


Publications

Search Publications
Appropriations
Audits
Bagels & Briefings
Briefing Papers
Digest of Legislation
Legislative Drafting Manual

Journals

Interim Highlights

Legislative Rules
GRAMA (Records Requests)
Public Email
State Organization Charts
YouTube Channel
Requests for Proposals and Legal Notices
More


Legislative Histories

Legislative History Resources
How to Research
Bill Drafting/Research Files (1990-Ongoing)

Working Bills (1896-1989)
Interim Committee Histories (1990-Ongoing) 
Journals
Past House Floor Debates
Past Senate Floor Debates
More


Staff Offices

All Legislative Offices
Auditor General
Fiscal Analyst
Printing
Research and General Counsel
Staff Awards
Job Opportunities
More


Links of Interest

Utah Administrative Rules
Courts
Utah State Capitol
State of Utah
Federal Legislation
More






 

Download Zipped Introduced WordPerfect HB0109.ZIP
[Status][Bill Documents][Fiscal Note][Bills Directory]


H.B. 109





            
1

    
 USE OF CONTROLLED SUBSTANCES IN RESEARCH



            
2

    
2012 GENERAL SESSION

            
3

    
STATE OF UTAH

            
4

    


 Chief Sponsor:  Dean Sanpei



            
5

    



Senate Sponsor:  






____________





            
6

    

            
7

    
 LONG TITLE
            
8

    
 General Description:
            
9

    
    This bill modifies the Utah Controlled Substances Act regarding licenses to conduct
            
10

    
research.
            
11

    
 Highlighted Provisions:
            
12

    
    This bill:
            
13

    
    .    specifies that the Division of Occupational and Professional Licensing may grant
            
14

    
licenses, under specified terms, to conduct research concerning Schedule 1
            
15

    
controlled substances.
            
16

    
 Money Appropriated in this Bill:
            
17

    
    None
            
18

    
 Other Special Clauses:
            
19

    
    None
            
20

    
 Utah Code Sections Affected:
            
21

    
AMENDS:
            
22

    
     58-37-6, as last amended by Laws of Utah 2011, Chapters 12 and 214
            
23

    

            
24

    
Be it enacted by the Legislature of the state of Utah:
            
25

    
    Section 11.  
Section  
58-37-6

 is amended to read:
            
26

    
     58-37-6.  License to manufacture, produce, distribute, dispense, administer, or
            
27

    
 conduct research -- Issuance by division -- Denial, suspension, or revocation -- Records

            
28


    
 required -- Prescriptions.
            
29

    
    (1) (a)  The division may adopt rules relating to the licensing and control of the
            
30

    
manufacture, distribution, production, prescription, administration, dispensing, conducting of
            
31

    
research with, and performing of laboratory analysis upon controlled substances within this
            
32

    
state.
            
33

    
    (b)  The division may assess reasonable fees to defray the cost of issuing original and
            
34

    
renewal licenses under this chapter pursuant to Section 

63J-1-504

.
            
35

    
    (2) (a) (i)  Every person who manufactures, produces, distributes, prescribes, dispenses,
            
36

    
administers, conducts research with, or performs laboratory analysis upon any controlled
            
37

    
substance in Schedules [II] I through V within this state, or who proposes to engage in
            
38

    
manufacturing, producing, distributing, prescribing, dispensing, administering, conducting
            
39

    
research with, or performing laboratory analysis upon controlled substances included in
            
40

    
Schedules [II] I through V within this state shall obtain a license issued by the division.
            
41

    
    (ii)  The division shall issue each license under this chapter in accordance with a
            
42

    
two-year renewal cycle established by rule.  The division may by rule extend or shorten a
            
43

    
renewal period by as much as one year to stagger the renewal cycles it administers.
            
44

    
    (b)  Persons licensed to manufacture, produce, distribute, prescribe, dispense,
            
45

    
administer, conduct research with, or perform laboratory analysis upon controlled substances in
            
46

    
Schedules [II] I through V within this state may possess, manufacture, produce, distribute,
            
47

    
prescribe, dispense, administer, conduct research with, or perform laboratory analysis upon
            
48

    
those substances to the extent authorized by their license and in conformity with this chapter.
            
49

    
    (c)  The following persons are not required to obtain a license and may lawfully possess
            
50

    
controlled substances included in Schedules II through V under this section:
            
51

    
    (i)  an agent or employee, except a sales representative, of any registered manufacturer,
            
52

    
distributor, or dispenser of any controlled substance, if the agent or employee is acting in the
            
53

    
usual course of the person's business or employment; however, nothing in this subsection shall
            
54

    
be interpreted to permit an agent, employee, sales representative, or detail man to maintain an
            
55

    
inventory of controlled substances separate from the location of the person's employer's
            
56

    
registered and licensed place of business;
            
57

    
    (ii)  a motor carrier or warehouseman, or an employee of a motor carrier or
            
58

    
warehouseman, who possesses any controlled substance in the usual course of the person's

            
59


    
business or employment; and
            
60

    
    (iii)  an ultimate user, or any person who possesses any controlled substance pursuant to
            
61

    
a lawful order of a practitioner.
            
62

    
    (d)  The division may enact rules waiving the license requirement for certain
            
63

    
manufacturers, producers, distributors, prescribers, dispensers, administrators, research
            
64

    
practitioners, or laboratories performing analysis if consistent with the public health and safety.
            
65

    
    (e)  A separate license is required at each principal place of business or professional
            
66

    
practice where the applicant manufactures, produces, distributes, dispenses, conducts research
            
67

    
with, or performs laboratory analysis upon controlled substances.
            
68

    
    (f)  The division may enact rules providing for the inspection of a licensee or applicant's
            
69

    
establishment, and may inspect the establishment according to those rules.
            
70

    
    (3) (a) (i)  Upon proper application, the division shall license a qualified applicant to
            
71

    
manufacture, produce, distribute, conduct research with, or perform laboratory analysis upon
            
72

    
controlled substances included in Schedules I through V, unless it determines that issuance of a
            
73

    
license is inconsistent with the public interest.
            
74

    
    (ii)  The division [shall] may not issue a license to any person to prescribe, dispense, or
            
75

    
administer a Schedule I controlled substance except under Subsection (3)(a)(i).
            
76

    
    (iii)  In determining public interest under this Subsection (3)(a), the division shall
            
77

    
consider whether or not the applicant has:
            
78

    
    [(i)] (A)  maintained effective controls against diversion of controlled substances and
            
79

    
any Schedule I or II substance compounded from any controlled substance into other than
            
80

    
legitimate medical, scientific, or industrial channels;
            
81

    
    [(ii)] (B)  complied with applicable state and local law;
            
82

    
    [(iii)] (C)  been convicted under federal or state laws relating to the manufacture,
            
83

    
distribution, or dispensing of substances;
            
84

    
    [(iv)] (D)  past experience in the manufacture of controlled dangerous substances;
            
85

    
    [(v)] (E)  established effective controls against diversion; and
            
86

    
    [(vi)] (F)  complied with any other factors that the division establishes that promote the
            
87

    
public health and safety.
            
88

    
    (b)  Licenses granted under Subsection (3)(a) do not entitle a licensee to manufacture,
            
89

    
produce, distribute, conduct research with, or perform laboratory analysis upon controlled

            
90


    
substances in Schedule I other than those specified in the license.
            
91

    
    (c) (i)  Practitioners shall be licensed to administer, dispense, or conduct research with
            
92

    
substances in Schedules II through V if they are authorized to administer, dispense, or conduct
            
93

    
research under the laws of this state.
            
94

    
    (ii)  The division need not require a separate license for practitioners engaging in
            
95

    
research with nonnarcotic controlled substances in Schedules II through V where the licensee is
            
96

    
already licensed under this chapter in another capacity.
            
97

    
    (iii)  With respect to research involving narcotic substances in Schedules II through V,
            
98

    
or where the division by rule requires a separate license for research of nonnarcotic substances
            
99

    
in Schedules II through V, a practitioner shall apply to the division prior to conducting
            
100

    
research.
            
101

    
    (iv)  Licensing for purposes of bona fide research with controlled substances by a
            
102

    
practitioner considered qualified may be denied only on a ground specified in Subsection (4),
            
103

    
or upon evidence that the applicant will abuse or unlawfully transfer or fail to safeguard
            
104

    
adequately the practitioner's supply of substances against diversion from medical or scientific
            
105

    
use.
            
106

    
    (v)  Practitioners registered under federal law to conduct research in Schedule I
            
107

    
substances may conduct research in Schedule I substances within this state upon furnishing the
            
108

    
division evidence of federal registration.
            
109

    
    (d)  Compliance by manufacturers, producers, and distributors with the provisions of
            
110

    
federal law respecting registration, excluding fees, entitles them to be licensed under this
            
111

    
chapter.
            
112

    
    (e)  The division shall initially license those persons who own or operate an
            
113

    
establishment engaged in the manufacture, production, distribution, dispensation, or
            
114

    
administration of controlled substances prior to April 3, 1980, and who are licensed by the
            
115

    
state.
            
116

    
    (4) (a)  Any license pursuant to Subsection (2) or (3) may be denied, suspended, placed
            
117

    
on probation, or revoked by the division upon finding that the applicant or licensee has:
            
118

    
    (i)  materially falsified any application filed or required pursuant to this chapter;
            
119

    
    (ii)  been convicted of an offense under this chapter or any law of the United States, or
            
120

    
any state, relating to any substance defined as a controlled substance;

            
121


    
    (iii)  been convicted of a felony under any other law of the United States or any state
            
122

    
within five years of the date of the issuance of the license;
            
123

    
    (iv)  had a federal registration or license denied, suspended, or revoked by competent
            
124

    
federal authority and is no longer authorized to manufacture, distribute, prescribe, or dispense
            
125

    
controlled substances;
            
126

    
    (v)  had the licensee's license suspended or revoked by competent authority of another
            
127

    
state for violation of laws or regulations comparable to those of this state relating to the
            
128

    
manufacture, distribution, or dispensing of controlled substances;
            
129

    
    (vi)  violated any division rule that reflects adversely on the licensee's reliability and
            
130

    
integrity with respect to controlled substances;
            
131

    
    (vii)  refused inspection of records required to be maintained under this chapter by a
            
132

    
person authorized to inspect them; or
            
133

    
    (viii)  prescribed, dispensed, administered, or injected an anabolic steroid for the
            
134

    
purpose of manipulating human hormonal structure so as to:
            
135

    
    (A)  increase muscle mass, strength, or weight without medical necessity and without a
            
136

    
written prescription by any practitioner in the course of the practitioner's professional practice;
            
137

    
or
            
138

    
    (B)  improve performance in any form of human exercise, sport, or game.
            
139

    
    (b)  The division may limit revocation or suspension of a license to a particular
            
140

    
controlled substance with respect to which grounds for revocation or suspension exist.
            
141

    
    (c) (i)  Proceedings to deny, revoke, or suspend a license shall be conducted pursuant to
            
142

    
this section and in accordance with the procedures set forth in Title 58, Chapter 1, Division of
            
143

    
Occupational and Professional Licensing Act, and conducted in conjunction with the
            
144

    
appropriate representative committee designated by the director of the department.
            
145

    
    (ii)  Nothing in this Subsection (4)(c) gives the Division of Occupational and
            
146

    
Professional Licensing exclusive authority in proceedings to deny, revoke, or suspend licenses,
            
147

    
except where the division is designated by law to perform those functions, or, when not
            
148

    
designated by law, is designated by the executive director of the Department of Commerce to
            
149

    
conduct the proceedings.
            
150

    
    (d) (i)  The division may suspend any license simultaneously with the institution of
            
151

    
proceedings under this section if it finds there is an imminent danger to the public health or

            
152


    
safety.
            
153

    
    (ii)  Suspension shall continue in effect until the conclusion of proceedings, including
            
154

    
judicial review, unless withdrawn by the division or dissolved by a court of competent
            
155

    
jurisdiction.
            
156

    
    (e) (i)  If a license is suspended or revoked under this Subsection (4), all controlled
            
157

    
substances owned or possessed by the licensee may be placed under seal in the discretion of the
            
158

    
division.
            
159

    
    (ii)  Disposition may not be made of substances under seal until the time for taking an
            
160

    
appeal has lapsed, or until all appeals have been concluded, unless a court, upon application,
            
161

    
orders the sale of perishable substances and the proceeds deposited with the court.
            
162

    
    (iii)  If a revocation order becomes final, all controlled substances shall be forfeited.
            
163

    
    (f)  The division shall notify promptly the Drug Enforcement Administration of all
            
164

    
orders suspending or revoking a license and all forfeitures of controlled substances.
            
165

    
    (g)  If an individual's Drug Enforcement Administration registration is denied, revoked,
            
166

    
surrendered, or suspended, the division shall immediately suspend the individual's controlled
            
167

    
substance license, which shall only be reinstated by the division upon reinstatement of the
            
168

    
federal registration, unless the division has taken further administrative action under
            
169

    
Subsection (4)(a)(iv), which would be grounds for the continued denial of the controlled
            
170

    
substance license.
            
171

    
    (5) (a)  Persons licensed under Subsection (2) or (3) shall maintain records and
            
172

    
inventories in conformance with the record keeping and inventory requirements of federal and
            
173

    
state law and any additional rules issued by the division.
            
174

    
    (b) (i)  Every physician, dentist, naturopathic physician, veterinarian, practitioner, or
            
175

    
other person who is authorized to administer or professionally use a controlled substance shall
            
176

    
keep a record of the drugs received by him and a record of all drugs administered, dispensed, or
            
177

    
professionally used by him otherwise than by a prescription.
            
178

    
    (ii)  A person using small quantities or solutions or other preparations of those drugs for
            
179

    
local application has complied with this Subsection (5)(b) if the person keeps a record of the
            
180

    
quantity, character, and potency of those solutions or preparations purchased or prepared by
            
181

    
him, and of the dates when purchased or prepared.
            
182

    
    (6)  Controlled substances in Schedules I through V may be distributed only by a

            
183


    
licensee and pursuant to an order form prepared in compliance with division rules or a lawful
            
184

    
order under the rules and regulations of the United States.
            
185

    
    (7) (a)  A person may not write or authorize a prescription for a controlled substance
            
186

    
unless the person is:
            
187

    
    (i)  a practitioner authorized to prescribe drugs and medicine under the laws of this state
            
188

    
or under the laws of another state having similar standards; and
            
189

    
    (ii)  licensed under this chapter or under the laws of another state having similar
            
190

    
standards.
            
191

    
    (b)  A person other than a pharmacist licensed under the laws of this state, or the
            
192

    
pharmacist's licensed intern, as required by Sections 

58-17b-303

 and 

58-17b-304

, may not
            
193

    
dispense a controlled substance.
            
194

    
    (c) (i)  A controlled substance may not be dispensed without the written prescription of
            
195

    
a practitioner, if the written prescription is required by the federal Controlled Substances Act.
            
196

    
    (ii)  That written prescription shall be made in accordance with Subsection (7)(a) and in
            
197

    
conformity with Subsection (7)(d).
            
198

    
    (iii)  In emergency situations, as defined by division rule, controlled substances may be
            
199

    
dispensed upon oral prescription of a practitioner, if reduced promptly to writing on forms
            
200

    
designated by the division and filed by the pharmacy.
            
201

    
    (iv)  Prescriptions reduced to writing by a pharmacist shall be in conformity with
            
202

    
Subsection (7)(d).
            
203

    
    (d)  Except for emergency situations designated by the division, a person may not issue,
            
204

    
fill, compound, or dispense a prescription for a controlled substance unless the prescription is
            
205

    
signed by the prescriber in ink or indelible pencil or is signed with an electronic signature of
            
206

    
the prescriber as authorized by division rule, and contains the following information:
            
207

    
    (i)  the name, address, and registry number of the prescriber;
            
208

    
    (ii)  the name, address, and age of the person to whom or for whom the prescription is
            
209

    
issued;
            
210

    
    (iii)  the date of issuance of the prescription; and
            
211

    
    (iv)  the name, quantity, and specific directions for use by the ultimate user of the
            
212

    
controlled substance.
            
213

    
    (e)  A prescription may not be written, issued, filled, or dispensed for a Schedule I

            
214


    
controlled substance[.] unless:
            
215

    
    (i)  the person to whom the prescription is issued is licensed under Subsection (2); and
            
216

    
    (ii)  the prescribed controlled substance is to be used in research.
            
217

    
    (f)  Except when administered directly to an ultimate user by a licensed practitioner,
            
218

    
controlled substances are subject to the following restrictions:
            
219

    
    (i) (A)  A prescription for a Schedule II substance may not be refilled.
            
220

    
    (B)  A Schedule II controlled substance may not be filled in a quantity to exceed a
            
221

    
one-month's supply, as directed on the daily dosage rate of the prescriptions.
            
222

    
    (ii)  A Schedule III or IV controlled substance may be filled only within six months of
            
223

    
issuance, and may not be refilled more than six months after the date of its original issuance or
            
224

    
be refilled more than five times after the date of the prescription unless renewed by the
            
225

    
practitioner.
            
226

    
    (iii)  All other controlled substances in Schedule V may be refilled as the prescriber's
            
227

    
prescription directs, but they may not be refilled one year after the date the prescription was
            
228

    
issued unless renewed by the practitioner.
            
229

    
    (iv)  Any prescription for a Schedule II substance may not be dispensed if it is not
            
230

    
presented to a pharmacist for dispensing by a pharmacist or a pharmacy intern within 30 days
            
231

    
after the date the prescription was issued, or 30 days after the dispensing date, if that date is
            
232

    
specified separately from the date of issue.
            
233

    
    (v)  A practitioner may issue more than one prescription at the same time for the same
            
234

    
Schedule II controlled substance, but only under the following conditions:
            
235

    
    (A)  no more than three prescriptions for the same Schedule II controlled substance may
            
236

    
be issued at the same time;
            
237

    
    (B)  no one prescription may exceed a 30-day supply;
            
238

    
    (C)  a second or third prescription shall include the date of issuance and the date for
            
239

    
dispensing; and
            
240

    
    (D)  unless the practitioner determines there is a valid medical reason to the contrary,
            
241

    
the date for dispensing a second or third prescription may not be fewer than 30 days from the
            
242

    
dispensing date of the previous prescription.
            
243

    
    (vi)  Each prescription for a controlled substance may contain only one controlled
            
244

    
substance per prescription form and may not contain any other legend drug or prescription

            
245


    
item.
            
246

    
    (g)  An order for a controlled substance in Schedules II through V for use by an
            
247

    
inpatient or an outpatient of a licensed hospital is exempt from all requirements of this
            
248

    
Subsection (7) if the order is:
            
249

    
    (i)  issued or made by a prescribing practitioner who holds an unrestricted registration
            
250

    
with the federal Drug Enforcement Administration, and an active Utah controlled substance
            
251

    
license in good standing issued by the division under this section, or a medical resident who is
            
252

    
exempted from licensure under Subsection 

58-1-307

(1)(c);
            
253

    
    (ii)  authorized by the prescribing practitioner treating the patient and the prescribing
            
254

    
practitioner designates the quantity ordered;
            
255

    
    (iii)  entered upon the record of the patient, the record is signed by the prescriber
            
256

    
affirming the prescriber's authorization of the order within 48 hours after filling or
            
257

    
administering the order, and the patient's record reflects the quantity actually administered; and
            
258

    
    (iv)  filled and dispensed by a pharmacist practicing the pharmacist's profession within
            
259

    
the physical structure of the hospital, or the order is taken from a supply lawfully maintained by
            
260

    
the hospital and the amount taken from the supply is administered directly to the patient
            
261

    
authorized to receive it.
            
262

    
    (h)  A practitioner licensed under this chapter may not prescribe, administer, or
            
263

    
dispense a controlled substance to a child, without first obtaining the consent required in
            
264

    
Section 

78B-3-406

 of a parent, guardian, or person standing in loco parentis of the child except
            
265

    
in cases of an emergency.  For purposes of this Subsection (7)(h), "child" has the same
            
266

    
meaning as defined in Section 

78A-6-105

, and "emergency" means any physical condition
            
267

    
requiring the administration of a controlled substance for immediate relief of pain or suffering.
            
268

    
    (i)  A practitioner licensed under this chapter may not prescribe or administer dosages
            
269

    
of a controlled substance in excess of medically recognized quantities necessary to treat the
            
270

    
ailment, malady, or condition of the ultimate user.
            
271

    
    (j)  A practitioner licensed under this chapter may not prescribe, administer, or dispense
            
272

    
any controlled substance to another person knowing that the other person is using a false name,
            
273

    
address, or other personal information for the purpose of securing the controlled substance.
            
274

    
    (k)  A person who is licensed under this chapter to manufacture, distribute, or dispense
            
275

    
a controlled substance may not manufacture, distribute, or dispense a controlled substance to

            
276


    
another licensee or any other authorized person not authorized by this license.
            
277

    
    (l)  A person licensed under this chapter may not omit, remove, alter, or obliterate a
            
278

    
symbol required by this chapter or by a rule issued under this chapter.
            
279

    
    (m)  A person licensed under this chapter may not refuse or fail to make, keep, or
            
280

    
furnish any record notification, order form, statement, invoice, or information required under
            
281

    
this chapter.
            
282

    
    (n)  A person licensed under this chapter may not refuse entry into any premises for
            
283

    
inspection as authorized by this chapter.
            
284

    
    (o)  A person licensed under this chapter may not furnish false or fraudulent material
            
285

    
information in any application, report, or other document required to be kept by this chapter or
            
286

    
willfully make any false statement in any prescription, order, report, or record required by this
            
287

    
chapter.
            
288

    
    (8) (a) (i)  Any person licensed under this chapter who is found by the division to have
            
289

    
violated any of the provisions of Subsections (7)(k) through (o) or Subsection (10) is subject to
            
290

    
a penalty not to exceed $5,000.  The division shall determine the procedure for adjudication of
            
291

    
any violations in accordance with Sections 

58-1-106

 and 

58-1-108

.
            
292

    
    (ii)  The division shall deposit all penalties collected under Subsection (8)(a)(i) in the
            
293

    
General Fund as a dedicated credit to be used by the division under Subsection 

58-37f-502

(1).
            
294

    
    (b)  Any person who knowingly and intentionally violates Subsections (7)(h) through (j)
            
295

    
or Subsection (10) is:
            
296

    
    (i)  upon first conviction, guilty of a class B misdemeanor;
            
297

    
    (ii)  upon second conviction, guilty of a class A misdemeanor; and
            
298

    
    (iii)  on third or subsequent conviction, guilty of a third degree felony.
            
299

    
    (c)  Any person who knowingly and intentionally violates Subsections (7)(k) through
            
300

    
(o) shall upon conviction be guilty of a third degree felony.
            
301

    
    (9)  Any information communicated to any licensed practitioner in an attempt to
            
302

    
unlawfully procure, or to procure the administration of, a controlled substance is not considered
            
303

    
to be a privileged communication.
            
304

    
    (10)  A person holding a valid license under this chapter who is engaged in medical
            
305

    
research may produce, possess, or administer, but may not prescribe or dispense, a controlled
            
306

    
substance listed in Section 

58-37-4.2

.





 Legislative Review Note
    as of   1-30-12  11:57 AM

 Office of Legislative Research and General Counsel
[Bill Documents][Bills Directory]









Who represents me?





Remember my Legislators





State Senate
		350 North State, Suite 320
		PO Box 145115
		Salt Lake City, Utah 84114

		Telephone: (801) 538-1035
		Fax: (801) 326-1475



House of Representatives
		350 North State, Suite 350
		PO Box 145030
		Salt Lake City, Utah 84114

		Telephone: (801) 538-1029
		Fax: (801) 326-1544










Home
Mobile Site
Site Map
Calendar
Code / Constitution
House
Senate

Terms of Use/Privacy Policy

ADA
Utah.gov







